Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human TARDBP/TDP43 Antibody (3H)

Catalog #:   RHG42201 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: DB, ELISA
Expression system: Mammalian Cells
Overview

Catalog No.

RHG42201

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

TARDBP, TDP43, TAR DNA-binding protein 43, TDP-43

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q13148

Applications

DB, ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

3H

Data Image
References

Virus-mediated delivery of single-chain antibody targeting TDP-43 protects against neuropathology, cognitive impairment and motor deficit caused by chronic cerebral hypoperfusion., PMID:39778789

Co-pathologies modify hippocampal protein accumulation patterns in neurodegenerative diseases., PMID:39711489

Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy., PMID:39400557

Vulnerability of neurofilament-expressing neurons in frontotemporal dementia., PMID:39369804

Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD., PMID:39363348

Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases., PMID:39160362

High-sensitivity in situ capture of endogenous RNA-protein interactions in fixed cells and primary tissues., PMID:39152130

Morphometric analysis of spinal motor neuron degeneration in sporadic amyotrophic lateral sclerosis., PMID:39146882

A patient-derived amyotrophic lateral sclerosis blood-brain barrier model for focused ultrasound-mediated anti-TDP-43 antibody delivery., PMID:39138578

Production and characterization of novel monoclonal antibodies against pathological human TDP-43 proteins., PMID:38728009

Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1., PMID:38522514

TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia., PMID:38232138

Colocalization of TDP-43 and stress granules at the early stage of TDP-43 aggregation in amyotrophic lateral sclerosis., PMID:37793650

Low T-cell reactivity to TDP-43 peptides in ALS., PMID:37545536

The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence., PMID:37359785

Integrated tandem affinity protein purification using the polyhistidine plus extra 4 amino acids (HiP4) tag system., PMID:36807525

Hyperphosphorylation-Mimetic TDP-43 Drives Amyloid Formation and Possesses Neuronal Toxicity at the Oligomeric Stage., PMID:36007056

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP., PMID:35879741

Gene Therapy in Amyotrophic Lateral Sclerosis., PMID:35805149

A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALS., PMID:35801182

Age-dependent formation of TMEM106B amyloid filaments in human brains., PMID:35344985

Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43., PMID:35264561

TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients., PMID:34835107

Aptamer-based enrichment of TDP-43 from human cells and tissues with quantification by HPLC-MS/MS., PMID:34469713

Phosphorylated TAR DNA-binding protein-43: Aggregation and antibody-based inhibition., PMID:34339840

[A case of facial-onset sensory and motor neuronopathy (FOSMN) with cerebellar ataxia and abnormal decrement in repetitive nerve stimulation test]., PMID:33504750

Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis., PMID:33479441

TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis., PMID:33361387

PCBP2 Is Downregulated in Degenerating Neurons and Rarely Observed in TDP-43-Positive Inclusions in Sporadic Amyotrophic Lateral Sclerosis., PMID:33313661

Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP., PMID:33300249

TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia., PMID:33065281

Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons., PMID:33021970

Stress Granule Assembly Can Facilitate but Is Not Required for TDP-43 Cytoplasmic Aggregation., PMID:32992901

Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein., PMID:32905837

Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants., PMID:32887544

Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes., PMID:32778941

Disposable immunoplatforms for the simultaneous determination of biomarkers for neurodegenerative disorders using poly(amidoamine) dendrimer/gold nanoparticle nanocomposite., PMID:32474723

Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes., PMID:32349792

Development of disease-modifying drugs for frontotemporal dementia spectrum disorders., PMID:32203398

Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS/FTD., PMID:32175624

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets., PMID:32090995

TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS., PMID:31882736

Autophagy Is a Common Degradation Pathway for Bunina Bodies and TDP-43 Inclusions in Amyotrophic Lateral Sclerosis., PMID:31504678

Muscle pathology of hereditary motor and sensory neuropathy with proximal dominant involvement with TFG mutation., PMID:31449671

Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies., PMID:31404106

C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation., PMID:31266542

Tau and TDP-43 accumulation of the basal nucleus of Meynert in individuals with cerebral lobar infarcts or hemorrhage., PMID:30922392

Morphology and Distribution of TDP-43 Pre-inclusions in Primary Progressive Aphasia., PMID:30753613

Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers., PMID:30075745

Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals., PMID:29662239

Datasheet
$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human TARDBP/TDP43 Antibody (3H) [RHG42201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only